OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting Neutrophils to Treat Acute Respiratory Distress Syndrome in Coronavirus Disease
Chih-Chao Chiang, Michal Korinek, Wei-Jen Cheng, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 107

Showing 1-25 of 107 citing articles:

Neutrophils in COVID-19
Nico Reusch, Elena De Domenico, Lorenzo Bonaguro, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 251

Neutrophils in COVID-19: recent insights and advances
Jiayu Li, Kegong Zhang, Ye Zhang, et al.
Virology Journal (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 42

Significance of NETs Formation in COVID-19
Karolina Janiuk, Ewa Jabłońska, Marzena Garley
Cells (2021) Vol. 10, Iss. 1, pp. 151-151
Open Access | Times Cited: 89

Neutrophils and COVID-19: Active Participants and Rational Therapeutic Targets
Jon Hazeldine, Janet M. Lord
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 73

Metoprolol in Critically Ill Patients With COVID-19
Agustín Clemente‐Moragón, Juan Martínez‐Milla, Eduardo Oliver, et al.
Journal of the American College of Cardiology (2021) Vol. 78, Iss. 10, pp. 1001-1011
Open Access | Times Cited: 63

Cell deaths: Involvement in the pathogenesis and intervention therapy of COVID-19
Xue Li, Ziqi Zhang, Zhenling Wang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 50

High generation of reactive oxygen species from neutrophils in patients with severe COVID-19
Tonny Veenith, H Martı́n, Martin Le Breuilly, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 50

Severe COVID-19 Shares a Common Neutrophil Activation Signature with Other Acute Inflammatory States
Lena F. Schimke, Alexandre H. C. Marques, G. Baiocchi, et al.
Cells (2022) Vol. 11, Iss. 5, pp. 847-847
Open Access | Times Cited: 39

Molecular Mechanisms of Rhabdomyolysis-Induced Kidney Injury: From Bench to Bedside
Jessica F. Hebert, Kevin G. Burfeind, Darren Malinoski, et al.
Kidney International Reports (2022) Vol. 8, Iss. 1, pp. 17-29
Open Access | Times Cited: 38

Persistent alveolar inflammatory response in critically ill patients with COVID-19 is associated with mortality
Justin de Brabander, Leonoor S. Boers, Robert F. J. Kullberg, et al.
Thorax (2023) Vol. 78, Iss. 9, pp. 912-921
Open Access | Times Cited: 25

A GPCR-neuropeptide axis dampens hyperactive neutrophils by promoting an alternative-like polarization during bacterial infection
Naina Gour, Hwan Mee Yong, Aishwarya Magesh, et al.
Immunity (2024) Vol. 57, Iss. 2, pp. 333-348.e6
Open Access | Times Cited: 10

Discovery of a novel C2-functionalized chromen-4-one scaffold for the development of p38α MAPK signaling inhibitors to mitigate neutrophilic inflammatory responses
Yi‐Han Chang, Yi-Chen Lee, Shun‐Hua Chen, et al.
Biochemical Pharmacology (2025) Vol. 235, pp. 116806-116806
Closed Access | Times Cited: 1

Human endogenous retrovirus K in the respiratory tract is associated with COVID-19 physiopathology
Jairo R. Temerozo, Natália Fintelman-Rodrigues, Monique Cristina dos Santos, et al.
Microbiome (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 30

Neutrophils in Cancer and Potential Therapeutic Strategies Using Neutrophil-Derived Exosomes
Abhishek Dutta, Shrikrishna Bhagat, Swastika Paul, et al.
Vaccines (2023) Vol. 11, Iss. 6, pp. 1028-1028
Open Access | Times Cited: 16

Myeloid-Derived Suppressor Cells as a Potential Biomarker and Therapeutic Target in COVID-19
Marianna Rowlands, Florencia Segal, Dominik Hartl
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 35

Phosphodiesterase Inhibitors in Acute Lung Injury: What Are the Perspectives?
Daniela Mokrá, Juraj Mokrý
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 4, pp. 1929-1929
Open Access | Times Cited: 34

Mild and Asymptomatic COVID-19 Convalescents Present Long-Term Endotype of Immunosuppression Associated With Neutrophil Subsets Possessing Regulatory Functions
Izabela Siemińska, Kazimierz Węglarczyk, Marcin Surmiak, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 33

A diminished immune response underlies age-related SARS-CoV-2 pathologies
Kohei Oishi, Shu Horiuchi, Justin J. Frere, et al.
Cell Reports (2022) Vol. 39, Iss. 13, pp. 111002-111002
Open Access | Times Cited: 26

VIP plasma levels associate with survival in severe COVID-19 patients, correlating with protective effects in SARS-CoV-2-infected cells
Jairo R. Temerozo, Carolina Q. Sacramento, Natália Fintelman-Rodrigues, et al.
Journal of Leukocyte Biology (2022) Vol. 111, Iss. 5, pp. 1107-1121
Open Access | Times Cited: 23

Mechanism-Driven Design of Multispecific Antibodies for Targeted Disease Treatment
Justyn Fine, Bunyarit Meksiriporn, Jiacheng Tan, et al.
Annual Review of Chemical and Biomolecular Engineering (2024) Vol. 15, Iss. 1, pp. 105-138
Closed Access | Times Cited: 5

Deficient neutrophil responses early in influenza infection promote viral replication and pulmonary inflammation
Henry H. Gong, Matthew J. Worley, Kyle A. Carver, et al.
PLoS Pathogens (2025) Vol. 21, Iss. 1, pp. e1012449-e1012449
Open Access

Predicting coronavirus disease 2019 severity using explainable artificial intelligence techniques
Takuya Ozawa, Shotaro Chubachi, Ho Namkoong, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access

Page 1 - Next Page

Scroll to top